ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

Lung Cancer in the Context of a Precision Medicine Approach

on: April 01, 2017In: Evolving Standards of Care
Lung Cancer in the Context of a Precision Medicine Approach

Posted: April 2017 By Giorgio Vittorio Scagliotti, MD, PhD The ambition to personalize medicine is intrinsic to the mission of every individual physician with the twin goals of reducing drug-related […] Read more


Efforts Aim to Make Clinical Trial Information More Accessible

on: February 01, 2017In: Evolving Standards of Care
Efforts Aim to Make Clinical Trial Information More Accessible

Posted: February 2017 By Cynthia L. Kryder, MS Clinical trials are essential to the development of new, potentially lifesaving therapies for patients with cancer. Well-designed clinical trials contribute to medical […] Read more

Drug Approval Processes Around the World: Focus on China

on: February 01, 2017In: Evolving Standards of Care
Drug Approval Processes Around the World: Focus on China

Posted: February 2017 By Caicun Zhou, MD As part of an ongoing series, IASLC Lung Cancer News is exploring how drug approval processes differ country by country, and continent by […] Read more

Impact of Clinical Pathways on Lung Cancer Management

on: February 01, 2017In: Evolving Standards of Care
Impact of Clinical Pathways on Lung Cancer Management

Posted: February 2017 Q&A with with Ronan J. Kelly, MB BCh, MBA Q: What is the impetus for the development of clinical pathways? A: The incidence of cancer in the US […] Read more

Drug Development in the 21st Century

on: February 01, 2017In: Evolving Standards of Care
Drug Development in the 21st Century

Posted: February 2017 By Lori Alexander, MTPW, ELS, MWC Drug development has become a biomarker- driven process, necessitating new approaches and clinical trial designs. Speakers addressed these issues in the […] Read more

NICE: It Takes Two to Tango

on: November 01, 2016In: Evolving Standards of Care
NICE: It Takes Two to Tango

By Sanjay Popat, FRCP, PhD United Kingdom Healthcare System The United Kingdom (UK) has a unique healthcare system: the National Health Service (NHS), a publicly funded, singlepayer system. Founded by […] Read more

What’s New from the 2016 ESMO Clinical Guidelines

on: November 01, 2016In: Evolving Standards of Care
What’s New from the 2016 ESMO Clinical Guidelines

By Matteo Giaj Levra, MD, and Silvia Novello MD, PhD In September, the 2016 ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up of metastatic nonsmall cell lung cancer (NSCLC) […] Read more

Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors”

on: September 01, 2016In: Evolving Standards of Care
Update to the “Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK
            Tyrosine Kinase Inhibitors”

The College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC), and Association for Molecular Pathology (AMP) published online in April 2013 the original “Molecular Testing […] Read more

National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

on: June 01, 2016In: Evolving Standards of Care
National Comprehensive Cancer Network NSCLC Guideline Updates for 2016: Non-Small Cell Lung Cancer

By Erik J. MacLaren, PhD The table at right lists key updates to the National Comprehensive Cancer Network (NCCN) Guidelines for NSCLC as of February 2016. These guidelines are not […] Read more

«‹16171819
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy